

- May 18, 2017
Factory workers show how private sector partnerships can empower more women to make healthy decision
CARE Cambodia is multiplying the impact of its Chat! Contraception package by offering this interactive training in more garment...


- May 10, 2017
The CARE-GSK partnership: Helping rural communities access healthcare
For four years, CARE has been working to improve access to quality healthcare in rural Cambodia with the support of GlaxoSmithKline....


- Dec 19, 2016
Chat! Contraception
Chat! Contraception is CARE Cambodia’s innovative package of activities to empower women to take control of their lives and make...


- Sep 8, 2016
CARE’s past and future efforts to improve health in Cambodia recognised at GSK launch event
This week saw CARE join the launch of the latest phase of GlaxoSmithKline (GSK)’s 20% Reinvestment Initiative. The event, which took...


- Jul 26, 2016
Training midwives benefits everyone
With more than 3 years experience, Sin Dany, a 29-year-old midwife from Thma Sar village in Cambodia, has delivered around 100 babies...


- Jul 20, 2016
Brighter futures for babies in Koh Kong
Men Savong is a 70-year-old former Traditional Birth Attendant (TBA). She is from Chiphat village in the south-west of Cambodia, a region...


- Feb 16, 2016
MCAT meetings giving midwives confidence
Midwifery Coordination Alliance Team (MCAT) meetings are designed to provide the link between midwives in health centres and hospital...


- Apr 19, 2015
Health education leads to healthy behaviours
“Villagers where I live used to seem careless about their health. They had limited knowledge about how to stay healthy; they didn’t get...
- Mar 25, 2015
Private sector partnership plans next step
CARE Cambodia recently hosted an event which brought together partners from across Asia to celebrate achivements in improving maternal...
- Jan 18, 2015
Fruitful partnership featured in video and publications
As 2014 drew to a close, CARE celebrated another successful year of partnership with GlaxoSmithKline in Cambodia. GlaxoSmithKline’s...